Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Cited In for PubMed (Select 18668643)

1.

Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma.

Narendra S, Jenkins SM, Khoor A, Nassar A.

Ann Diagn Pathol. 2015 Apr;19(2):64-9. doi: 10.1016/j.anndiagpath.2015.01.005. Epub 2015 Jan 22.

2.

Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies.

Assefnia S, Dakshanamurthy S, Guidry Auvil JM, Hampel C, Anastasiadis PZ, Kallakury B, Uren A, Foley DW, Brown ML, Shapiro L, Brenner M, Haigh D, Byers SW.

Oncotarget. 2014 Mar 30;5(6):1458-74.

3.

Invasive pleomorphic lobular carcinoma of the breast: clinicopathologic characteristics and prognosis compared with invasive ductal carcinoma.

Jung SP, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kim M, Kil WH, Cho EY, Choe JH, Kim JH, Kim JS, Nam SJ, Lee JE.

J Breast Cancer. 2012 Sep;15(3):313-9. doi: 10.4048/jbc.2012.15.3.313. Epub 2012 Sep 28.

4.

Invasive pleomorphic lobular carcinoma, negative for ER, PR and Her/2neu--a case report.

Manucha V, Khilko N, Reilly K, Zhang X.

Int J Clin Exp Pathol. 2011 Jan 30;4(2):200-5.

5.

Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice.

Derksen PW, Braumuller TM, van der Burg E, Hornsveld M, Mesman E, Wesseling J, Krimpenfort P, Jonkers J.

Dis Model Mech. 2011 May;4(3):347-58. doi: 10.1242/dmm.006395. Epub 2011 Jan 31.

6.

Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17.

Khilko N, Wang J, Wei B, Hicks DG, Tang P.

Breast Cancer (Auckl). 2010 Oct 21;4:49-55. doi: 10.4137/BCBCR.S5037.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk